Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Angelo, D. D.
Right arrow Articles by Dorn, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Angelo, D. D.
Right arrow Articles by Dorn, G. W., II
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 11, Issue of March 15, 1996 pp. 6233-6240
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Mutagenic Analysis of Platelet Thromboxane Receptor Cysteines
ROLES IN LIGAND BINDING AND RECEPTOR-EFFECTOR COUPLING

(Received for publication, September 7, 1995; and in revised form, December 22, 1995)

Drew D. D'Angelo Jeremy J. Eubank Michael G. Davis Gerald W. Dorn II

The human platelet thromboxane A(2) receptor is a member of the G-protein-coupled superfamily of receptors. Previous pharmacologic studies examining the effects of biochemical reduction, oxidation, or sulfhydryl alkylation on thromboxane receptors have suggested a role for cysteines in determining receptor binding characteristics. To characterize the roles of individual cysteines, we employed site-directed mutagenesis to substitute serines for cysteines at seven positions throughout the human K562 thromboxane receptor and analyzed mutant receptor radioligand ([1S-(1alpha,2beta(5Z),3alpha(1E,3S),4alpha]-7-[3-(3-hydroxy-4-(p-iodophenoxy)-1-butenyl)-7-oxabicyclo-[2.2.1]heptane-2-yl]-5-heptenoic acid) binding and calcium signaling. Replacing cysteines in the amino terminus (amino acid position 11), and transmembrane domains two and six (positions 68 and 257) had little effect on thromboxane receptor binding or signaling. Introduction of serines for cysteines in the first (position 105) or the second (position 183) extracellular loop eliminated thromboxane receptor binding, consistent with the existence of a critical disulfide bond between these positions. Mutation of a second cysteine in extracellular loop one (position 102) resulted in a receptor with decreased binding affinity and low binding capacity that transduced only a low amplitude calcium signal, suggesting the involvement of a free sulfhydryl group at this location in receptor-ligand interactions. Finally, mutation of the cysteine at position 223, located in intracellular loop three, resulted in a receptor with normal ligand binding characteristics, but which did not transduce a calcium signal. Some additional amino acid substitutions in this region of the receptor (Cys-223 Ala, Thr-221 Met) resulted in receptors that had normal binding but transduced low amplitude calcium signals, while other mutations in the same region (His-224 Arg and His-227 Arg) exhibited normal binding and calcium signaling characteristics. These findings demonstrate that cysteines in extracellular loops one and two contribute to proper ligand binding to thromboxane receptors and show the importance of discrete amino acid sequences in the third intracellular loop, especially cysteine 223, in thromboxane receptor-effector coupling.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Stitham, S. R. Gleim, K. Douville, E. Arehart, and J. Hwa
Versatility and Differential Roles of Cysteine Residues in Human Prostacyclin Receptor Structure and Function
J. Biol. Chem., December 1, 2006; 281(48): 37227 - 37236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. T. Khasawneh, J.-S. Huang, J. W. Turek, and G. C. L. Breton
Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein
J. Biol. Chem., September 15, 2006; 281(37): 26951 - 26965.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Capra, A. Veltri, C. Foglia, L. Crimaldi, A. Habib, M. Parenti, and G. E. Rovati
Mutational Analysis of the Highly Conserved ERY Motif of the Thromboxane A2 Receptor: Alternative Role in G Protein-Coupled Receptor Signaling
Mol. Pharmacol., October 1, 2004; 66(4): 880 - 889.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Ding, S. Kim, R. T. Dorsam, J. Jin, and S. P. Kunapuli
Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270
Blood, May 15, 2003; 101(10): 3908 - 3914.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-P. So, J. Wu, G. Huang, A. Huang, D. Li, and K.-H. Ruan
Identification of Residues Important for Ligand Binding of Thromboxane A2 Receptor in the Second Extracellular Loop Using the NMR Experiment-guided Mutagenesis Approach
J. Biol. Chem., March 21, 2003; 278(13): 10922 - 10927.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Turek, T. Halmos, N. L. Sullivan, K. Antonakis, and G. C. Le Breton
Mapping of a Ligand-binding Site for the Human Thromboxane A2 Receptor Protein
J. Biol. Chem., May 3, 2002; 277(19): 16791 - 16797.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al.
Prostanoid receptors: ontogeny and implications in vascular physiology
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-O. Chung, Q. Yang, K. J. Catt, and K. K. Arora
Expression and Function of the Gonadotropin-releasing Hormone Receptor Are Dependent on a Conserved Apolar Amino Acid in the Third Intracellular Loop
J. Biol. Chem., December 10, 1999; 274(50): 35756 - 35762.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Narumiya, Y. Sugimoto, and F. Ushikubi
Prostanoid Receptors: Structures, Properties, and Functions
Physiol Rev, October 1, 1999; 79(4): 1193 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. A. Stillman, M. D. Breyer, and R. M. Breyer
Importance of the Extracellular Domain for Prostaglandin EP2 Receptor Function
Mol. Pharmacol., September 1, 1999; 56(3): 545 - 551.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Pawate, K. L. Schey, G. P. Meier, M. E. Ullian, D. E. Mais, and P. V. Halushka
Expression, Characterization, and Purification of C-terminally Hexahistidine-tagged Thromboxane A2 Receptors
J. Biol. Chem., August 28, 1998; 273(35): 22753 - 22760.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. T. Walsh, J. F. Foley, and B. T. Kinsella
Characterization of the Role of N-Linked Glycosylation on the Cell Signaling and Expression of the Human Thromboxane A2 Receptor Alpha and Beta Isoforms
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1026 - 1036.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. F. Spurney and T. M. Coffman
The C-Terminus of the Thromboxane Receptor Contributes to Coupling and Desensitization in a Mouse Mesangial Cell Line
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 207 - 215.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. S. Monteclaro and I. F. Charo
The Amino-terminal Domain of CCR2 Is Both Necessary and Sufficient for High Affinity Binding of Monocyte Chemoattractant Protein 1. RECEPTOR ACTIVATION BY A PSEUDO-TETHERED LIGAND
J. Biol. Chem., September 12, 1997; 272(37): 23186 - 23190.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Audoly and R. M. Breyer
The Second Extracellular Loop of the Prostaglandin EP3 Receptor Is an Essential Determinant of Ligand Selectivity
J. Biol. Chem., May 23, 1997; 272(21): 13475 - 13478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. W. Dorn II, M. G. Davis, and D. D. D'Angelo
Structural Determinants for Agonist Binding Affinity to Thromboxane/Prostaglandin Endoperoxide (TP) Receptors. ANALYSIS OF CHIMERIC RAT/HUMAN TP RECEPTORS
J. Biol. Chem., May 9, 1997; 272(19): 12399 - 12405.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement